Lilly's Dupixent rival works in phase 3 atopic dermatitis trial
Boehringer ends $600M cancer pact with CureVac
Inside the Sanofi--Translate Bio deal
Merck kicks off rolling submission of its oral COVID antiviral with Canada
*please scroll down for all the latest news*
